![James Dentzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Dentzer
Chief Executive Officer at
CURIS, INC.
Net worth: 116 949 $ as of 31/05/2026
Profile
James E.
Dentzer is President, Chief Executive Officer & Director at Curis, Inc. since 2019 and Independent Director at Imunon, Inc. since 2022.
Former roles include Chief Financial Officer-DuPont Flooring Systems at EIDP, Inc., Controller at Biogen, Inc. from 2003 to 2006, Chief Financial Officer at Amicus Therapeutics, Inc. from 2006 to 2009, Chief Financial Officer at Valeritas, Inc. from 2010 to 2013, and Chief Financial Officer at Dicerna Pharmaceuticals, Inc. from 2013 to 2015.
Education includes undergraduate studies at Boston College and an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CURIS, INC. 0.38% | 01/05/2026 | 148,730 ( 0.38% ) | 84 330 $ | 31/05/2026 |
IMUNON, INC. 0.59% | 22/05/2026 | 14,963 ( 0.59% ) | 32 619 $ | 31/05/2026 |
James Dentzer active positions
| Companies | Position | Start |
|---|---|---|
| CURIS, INC. | Chief Executive Officer | 24/09/2018 |
| IMUNON, INC. | Director/Board Member | 03/09/2022 |
Former positions of James Dentzer
| Companies | Position | End |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Director of Finance/CFO | 15/12/2015 |
| VALERITAS INC | Director of Finance/CFO | 01/12/2013 |
| AMICUS THERAPEUTICS, INC. | Director of Finance/CFO | 29/10/2009 |
| BIOGEN INC. | Comptroller/Controller/Auditor | - |
| E I DU PONT DE NEMOURS AND CO | Corporate Officer/Principal | - |
Training of James Dentzer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
56
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries Manufactures and sells seed & crop protection products | Process Industries |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- James Dentzer
